[1]林文麟,林建南△,陈志慧,等.和胃平肝饮治疗痰湿阻络型颈椎病的临床观察[J].中国中医骨伤科杂志,2026,34(03):79-83.[doi:10.20085/j.cnki.issn1005-0205.260312]
　LIN Wenlin,LIN Jiannan,CHEN Zhihui,et al.Clinical Observation on the Treatment of Cervical Spondylosis with Phlegm-Dampness Obstructing Meridians by He Wei Ping Gan Decoction[J].Chinese Journal of Traditional Medical Traumatology & Orthopedics,2026,34(03):79-83.[doi:10.20085/j.cnki.issn1005-0205.260312]
点击复制

和胃平肝饮治疗痰湿阻络型颈椎病的临床观察()

《中国中医骨伤科杂志》[ISSN:1005-0205/CN:42-1340/R]

卷:
第34卷
期数:
2026年03期
页码:
79-83
栏目:
临床研究
出版日期:
2026-03-15

文章信息/Info

Title:
Clinical Observation on the Treatment of Cervical Spondylosis with Phlegm-Dampness Obstructing Meridians by He Wei Ping Gan Decoction
文章编号:
1005-0205(2026)03-0079-05
作者:
林文麟1; 林建南1△; 陈志慧1; 林定华1; 许一雷1; 胡心影1; 叶朱文1
1瑞安市中医院(浙江 瑞安,325200)
Author(s):
LIN Wenlin1; LIN Jiannan1△; CHEN Zhihui1; LIN Dinghua1; XU Yilei1; HU Xinying1; YE Zhuwen1
1Rui'an Hospital of Traditional Chinese Medicine,Ruian 325200,Zhejiang China.
关键词:
痰湿阻络;  颈椎病;  和胃平肝饮;  阳明为先;  临床观察
Keywords:
phlegm-dampness obstructing the meridians;  cervical spondylosis;  He Wei Ping Gan decoction;  Yangming channel involved first;  clinical observation
分类号:
R681.5
DOI:
10.20085/j.cnki.issn1005-0205.260312
文献标志码:
A
摘要:
目的:探讨和胃平肝饮在治疗痰湿阻络型颈椎病中的临床效果。方法:选取2024年8月至2025年5月收治的72例痰湿阻络型颈椎病(椎动脉型)患者,采用随机数字表法将其分为两组,观察组和对照组各36例。对照组患者给予塞来昔布胶囊基础治疗,观察组患者给予和胃平肝饮治疗,治疗周期为14 d。观察比较两组患者的临床疗效、不良反应发生率及治疗前后中医证候评分、ESCV评分、NDI评分、JOA评分和椎基底动脉血流动力学指标。结果:治疗后观察组总有效率达91.7%(33/36),明显优于对照组(75.0%,27/36),两组之间差异有统计学意义(P<0.05)。两组中医证候评分与治疗前比较差异有统计学意义(P<0.05),同时观察组与对照组相比,其证候评分明显降低,差异有统计学意义(P<0.05)。两组ESCV评分与治疗前比较差异有统计学意义(P<0.05),观察组得分明显下降且低于对照组,差异有统计学意义(P<0.05)。两组患者NDI评分相较于治疗前均降低,差异有统计学意义(P<0.05); 而JOA评分相对于治疗前有所提高,差异有统计学意义(P<0.05); 观察组这两项指标的改善与对照组相比差异有统计学意义(P<0.05)。椎基底动脉各项参数两组患者均相对于治疗前有明显的改善(P<0.05),观察组患者各项参数变化与对照组比差异有统计学意义(P<0.05)。在治疗周期内各组患者的不良反应发生率差异无统计学意义(P>0.05)。结论:和胃平肝饮能够明显提高痰湿阻络型颈椎病患者的颈椎功能,改善椎基底动脉的血液动力学指标,减轻眩晕等症状,是一种安全、有效的治疗方法。
Abstract:
Objective:To explore the clinical effect of He Wei Ping Gan decoction in the treatment of the cervical spondylosis of phlegm-dampness blocking the collaterals type(vertebral artery type).Methods:A total of 72 patients with cervical spondylosis of the phlegm-dampness blocking the collaterals type(vertebral artery type)from August 2024 to May 2025 were selected and randomly divided into two groups(observation group and control group)using the random number table method,with 36 patients in each group.The control group received celecoxib capsules as the basic treatment,while the observation group was treated with He Wei Ping Gan decoction.The treatment duration was 14 d.Then,the clinical efficacy,adverse reaction rate,and TCM syndrome scores,ESCV scores,NDI scores,JOA scores,and hemodynamic parameters of the vertebral basilar artery were observed and compared between the two groups before and after treatment.Results:After treatment,the total effective rate of the observation group was 91.7%(33/36),which was significantly higher than that of the control group(75.0%,27/36),and the difference between the two groups was statistically significant(P<0.05).There was a significant difference in TCM syndrome scores compared with those before treatment(P<0.05),and the syndrome scores of the observation group were significantly lower than those of the control group(P<0.05).There was a significant difference in ESCV scores compared with those before treatment(P<0.05),and the scores of the observation group decreased significantly and were lower than those of the control group(P<0.05).The NDI scores of both groups decreased compared with those before treatment(P<0.05),and the JOA scores increased compared with those before treatment(P<0.05).The improvements of these two indicators in the observation group were significantly different from those in the control group(P<0.05).In terms of the parameters of the vertebral basilar artery,both groups showed significant improvement compared with those before treatment(P<0.05),and the changes in the parameters of the observation group were significantly different from those of the control group(P<0.05).Finally,there was no significant difference in the incidence of adverse reactions between the two groups during the treatment period(P>0.05).Conclusion:He Wei Ping Gan decoction can significantly improve cervical function in patients with phlegm-dampness obstructing the collaterals type of cervical spondylosis,enhance hemodynamic parameters of the vertebral-basilar artery,and alleviate symptoms such as dizziness.It is a safe and effective treatment approach.

参考文献/References:

[1] 章薇,李金香,娄必丹,等.中医康复临床实践指南·项痹(颈椎病)[J].康复学报,2020,30(5):337-342.
[2] 庞晓东,吴兵,高春华,等.颈椎间盘源性头晕发病机制研究进展[J].中华疼痛学杂志,2022,18(5):707-711.
[3] 金明卜,王海宁,孙辉,等.针刺在颈椎病治疗中的作用及对椎动脉血流动力学、疼痛介质、内皮素、颈椎功能等的影响研究[J/OL].中华中医药学刊,1-7[2025-08-08].https://link.cnki.net/urlid/21.1546.R.20250912.1303.018
[4] MENG F Q,XU S,LIANG Y,et al.Cervical balance and clinical outcomes in cervical spondylotic myelopathy treated by three-level anterior cervical discectomy and fusion and hybrid cervical surgery:a CONSORT-compliant study with minimum follow-up period of 5 years[J].Medicine,2021,100(18):e25824.
[5] 王鑫,李艾琳,闫绍妹,等.平衡针刀联合温针灸治疗椎动脉型颈椎病的疗效观察[J].针刺研究,2022,47(7):625-629.
[6] 郭六玲,高红娟,郭鹏.当归川芎汤联合晕三针治疗椎动脉型颈椎病眩晕疗效分析[J].中西医结合研究,2025,17(4):228-231.
[7] 张燕.颈眩汤治疗椎动脉型颈椎病痰瘀阻络型临床体会[J].实用中医药杂志,2022,38(9):1638-1639.
[8] 王林娟,陈家平,丁明俊,等.定眩通络方联合透灸法治疗痰湿阻络型混合型颈性眩晕临床研究[J].山东中医杂志,2025,44(3):302-307.
[9] 李孔正,刘业帅,谭明芳,等.基于“太阴主湿”肺脾同治针刺治疗痰湿阻络型颈型颈椎病的临床研究[J].中外医学研究,2023,21(21):1-5.
[10] 中华外科杂志编辑部.颈椎病的分型、诊断及非手术治疗专家共识(2018)[J].中华外科杂志,2018,56(6):401-402.
[11] 国家中医药管理局医政司.中医病证诊断疗效标准[S].北京:中国中医药出版社,2017.
[12] 陈刚,刘泽华.颈椎病中医辨证分型与影像分析[J].世界最新医学信息文摘,2015,15(36):102.
[13] 柳开阳.平乐正骨配合抗阻运动治疗颈性眩晕的临床研究[J].按摩与康复医学,2022,13(6):1-3.
[14] 罗金峰,秋曙祎,王志民,等.颈椎后路单开门椎管扩大成形跳跃式与连续性微型钛板固定治疗多节段脊髓型颈椎病的Meta分析[J].中医正骨,2023,35(10):31-36.
[15] 任树军,黄柄祥,王墉琦,等.超声引导下刃针松解颈椎横突后结节治疗神经根型颈椎病的临床研究[J].中国中医急症,2022,31(10):1742-1744.
[16] 国家食品药品监督管理局.中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,2002.
[17] 刘献强,唐臻一,王博韬,等.近5年中医药治疗颈型颈椎病研究进展[J].光明中医,2022,37(10):1882-1884.
[18] 王凯,宋敏,巩彦龙,等.活血定眩胶囊治疗椎动脉型颈椎病的临床疗效与药理作用研究进展[J].中成药,2023,45(11):3708-3712.
[19] 郜顺兴.我国颈椎病定义及分型的历史沿革[J].中医正骨,2020,32(4):44-47.
[20] 梅杰,梅国强.国医大师梅国强辨治颈椎病经验初探[J].中华中医药杂志,2020,35(2):706-708.
[21] 张汗,张琦.试论温中燠土法治疗颈椎病[J].中华中医药杂志,2017,32(1):187-190.
[22] 徐善达,孔令军,朱清广,等.颈型颈椎病“筋骨失衡”的运动学特性研究[J].中华中医药杂志,2020,35(9):4739-4742.
[23] 彭斯伟,宋敏,范凯.基于络病理论探讨络虚通补法在气虚血瘀型椎动脉型颈椎病中的应用[J].世界科学技术-中医药现代化,2021,23(7):2461-2466.
[24] 侯宇龙,王晶石,赵文海,等.国医大师刘柏龄治疗脊髓型颈椎病用药规律探析[J].世界科学技术-中医药现代化,2021,23(7):2467-2472.
(收稿日期:2025-08-16)

备注/Memo

备注/Memo:
基金项目:浙江省中医药科技计划项目(2025ZX220)
△通信作者 E-mail:775189262@qq.com
更新日期/Last Update: 2026-03-15